RT Journal Article
SR Electronic
T1 Association of aortic clamping time with systemic immune inflammation and systemic inflammatory response indexes in isolated coronary bypass surgery
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.04.22.24306198
DO 10.1101/2024.04.22.24306198
A1 Durmaz, Duygu
A1 Gündöner, Sedat
A1 Tekümit, Hayrettin
YR 2024
UL http://medrxiv.org/content/early/2024/04/23/2024.04.22.24306198.abstract
AB Objective Aortic clamping time during cardiopulmonary bypass (CPB) has been associated with inflammatory processes such as systemic inflammatory response syndrome. In this study, we evaluated the association of CPB and aortic cross-clamping (ACC) times with systemic inflammatory response index (SIRI) and systemic immune inflammation index (SIII) in isolated coronary artery bypass surgery (CABG).Methods 96 patients who underwent isolated CABG at a single center between 2021 and 2023 were retrospectively analyzed. Patients were divided into below median aortic clamp time (group I; n=56) and above median aortic clamp time (group II; n=42) according to median aortic clamp time (66.2 minutes). Demographic data, preoperative and postoperative laboratory parameters were recorded. SIRI and SIII values were calculated.Results Baseline demographic data were similar between the groups. The duration of CPB and aortic clamping was significantly longer in group II (p<0.001). SIII and SIRI values were significantly increased in both groups in the postoperative period. However, there was no correlation between increased CPB and ACC durations and SIII and SIRI. However, no significant difference was observed in postoperative SIII and SIRI values between the groups. A weak correlation was found between SIII index and postoperative albumin levels.Conclusions There is no significant relationship between aortic clamping time and inflammatory indices in patients undergoing isolated CABG surgery. Increasing the duration of surgery does not affect the change in SIRI and SIII values.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialThis is a retrospectively designed studyFunding Statementthere is no funding support in this textAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:BANDIRMA 17 EYLÜL UNIVERSITY RECTORATE HEALTH SCIENCES NON-INTERVENTIONAL RESEARCH ETHICS COMMITTEEI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesThe availability of data for all citations in this article is based on information taken from relevant sources and believed to be reliable.